News

BMJ1d
AB0551 HIGH-DOSE ORAL THIAMINE TREATMENT AGAINST CHRONIC FATIGUE IN PATIENTS WITH RHEUMATOID ARTHRITIS. A RANDOMISED CONTROLLED CROSS-OVER TRIAL
1 Department of Rheumatology, Aarhus University Hospital, Department of Rheumatology, Aarhus, Denmark 2 Department of Rheumatology, Aarhus University Hospital, Department of Rheumatology, Aarhus, ...
BMJ1d
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores
2 Rheumatology Department, Leiden University Medical Center, Leiden, The Netherlands 3 Rheumatology Department, Maastricht University Medical Center, Maastricht, The Netherlands Background The ...
BMJ1d
AB0319 HIGH PREVALENCE OF HYPOALBUMINEMIA IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
Background Hypoalbuminemia is associated with worse medical conditions in chronic diseases and surgery outcomes. The concentration of serum albumin in patients with rheumatoid arthritis (RA) has been ...
BMJ1d
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study
Objective To evaluate the efficacy and safety of etanercept (ETN) after 48 weeks in patients with early active non-radiographic axial spondyloarthritis (nr-axSpA). Methods Patients meeting Assessment ...
BMJ3d
Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis
1 Department of Medicine, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA 2 Division of Rheumatology, David Geffen School of Medicine at University of California Los Angeles, Los ...
BMJ3d
A disease activity score for polymyalgia rheumatica
Objective: To develop a composite score for measurement of disease activity in polymyalgia rheumatica (PMR) and assess its internal and external validity. Methods: A PMR activity score (AS) was ...
BMJ3d
Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial
VU University Medical Center, Clinical Epidemiology & Biostatistics, Amsterdam, The Netherlands Lilian H D van Tuyl, VU University Medical Center, Department of Clinical Epidemiology & Biostatistics, ...
BMJ6d
POS0680 BELIMUMAB ADD-ON THERAPY MOBILISES MEMORY B CELLS INTO THE CIRCULATION OF PATIENTS WITH SLE
Objectives: To investigate dynamics of B-cell subsets in SLE patients treated with or without BLM, with a focus on assessing MBC characteristics. Results: By employing HS flowcytometry, we established ...
BMJ6d
2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis
Background An important but often insufficient aspect of care in people with inflammatory arthritis (IA) is empowering patients to acquire a good understanding of their disease and building their ...
BMJ6d
Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis
Correspondence to Dr Adrian Ciurea, Department of Rheumatology, University Hospital Zurich, Gloriastrasse 25, Zurich CH-8091, Switzerland; adrian.ciurea{at}usz.ch Objectives To investigate the impact ...
BMJ6d
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel
17 Department of Gerontology & Geriatrics VUB, University Hospital, Brussels, Belgium 18 Department of Geriatric Medicine, University Hospital Ghent, Ghent, Belgium Introduction Given the safety ...